TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05563948

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Vaporized cannabis will be administered 3x/day for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Vaporized cannabis will be administered 3x/day for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Vaporized cannabis will be administered 3x/day for 15 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cannabis
Description: Vaporized cannabis will be administered 3x/day for 15 days.
Study: NCT06654947

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib+Toripalimab+GEMOX
Description: Surufatinib (200mg，qd，Q3W）；Toripalimab(240mg IV d1, Q3W)；GEMOX：Gemcitabine: 1000 mg/m2, IV，d1，d8，Q3W，Oxaliplatin：100mg/m2,ivgtt，d1，Q3W）
Study: NCT05001880

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood and tissue sample collection

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood and tissue sample collection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cytoreductive Surgery
Description: Undergo surgery

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cytoreductive Surgery
Description: Undergo surgery

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperthermic Intraperitoneal Chemotherapy
Description: Undergo HIPEC

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyperthermic Intraperitoneal Chemotherapy
Description: Undergo HIPEC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET scan

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Positron Emission Tomography
Description: Undergo PET scan
Study: NCT06678373

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Description: The patient needs to receive 1 dose of inactivated Japanese encephalitis vaccine.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Description: The patient needs to receive 2 doses of inactivated Japanese encephalitis vaccine, with an interval of 28 days.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Description: The patient needs to receive 2 doses of inactivated Japanese encephalitis vaccine, with an interval of 7 days.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Description: The patient needs to receive 2 doses of inactivated Japanese encephalitis vaccine, with an interval of 7 days.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Description: The patient needs to receive 2 doses of inactivated Japanese encephalitis vaccine, with an interval of 7 days.
Study: NCT06626425

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Healthy Minds Program App
Description: An 8-week meditation-based well-being training containing content for each of the four pillars of the training program: Awareness, Connection, Insight, and Purpose.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hydro Coach App
Description: The Hydro Coach app (HC). A smartphone-based wellness app to ensure proper hydration.
Study: NCT06683560

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: : photopolymer resin material graphy Tera Harz 85 will be used to print 3D printed aligners for NAM treatment
Description: 3d printed NAM aligner is made from novel photopolymer resin as a novel device
Study: NCT06717230

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EverX Posterior
Description: Restoration

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: EverX Posterior
Description: Restoration
Study: NCT06725017

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Live SK08 powder
Description: SK08 is an investigational live biotherapeutic product containing a nontoxigenic B. fragilis(NTBF) strain as an active ingredient.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Live SK08 powder
Description: SK08 is an investigational live biotherapeutic product containing a nontoxigenic B. fragilis(NTBF) strain as an active ingredient.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06734156

Intervention type: OTHER
Intervention: No intervention: observational study
Description: No intervention: observational study
Study: NCT06736067

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Thirty minutes of exercise on a treadmill, including a 5-minute warm-up followed by increments in speed until reaching optimal moderate to high intensity (60-80% of age-predicted maximal heart rate), which will be maintained for 20 min, followed by a 5-minute cool-down. Age-predicted maximal HR will be defined as 220 beats-per-minute (BPM) minus age in years.
Study: NCT06734611

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fortified Iodized Salt with Folic Acid (FISFA)
Description: Addition of folic acid to iodized salt for daily consumption to assess folate levels.
Study: NCT06736483

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Intravenous administration of 1 µg /kg of dexmedetomidine in 10 ml of 0.9% sodium chloride at the time of incision.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo administration
Description: Intravenous administration of 10 ml sodium chloride 0.9% at the time of incision

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Face Legs Activity Cry Consolability scale
Description: The pain will be assessed on admission and every 15 minutes until discharge from the PACU

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Face Legs Activity Cry Consolability scale
Description: The pain will be assessed on admission and every 15 minutes until discharge from the PACU

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-Hospitalization Behavior Questionnaire
Description: The Post-Hospitalization Behavior Questionnaire will be completed at day 1 and at day 7

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Post-Hospitalization Behavior Questionnaire
Description: The Post-Hospitalization Behavior Questionnaire will be completed at day 1 and at day 7

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postoperative pain measure
Description: The Postoperative pain measure will be completed by parents at day 1, day 7, 3 months and 6 months

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Postoperative pain measure
Description: The Postoperative pain measure will be completed by parents at day 1, day 7, 3 months and 6 months

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-operative quality of life questionnaire
Description: The Post-operative quality of life questionnaire pedQL will be completed at 3 and 6 months

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Post-operative quality of life questionnaire
Description: The Post-operative quality of life questionnaire pedQL will be completed at 3 and 6 months
Study: NCT06735794

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Compressed iTBS
Description: Intermittent Theta-Burst Stimulation (iTBS) is a form of non-invasive brain stimulation that uses magnetic pulses applied to the scalp using a coil. iTBS will be used to stimulate the left motor cortex to enhance long-term potentiation (LTP)-like activity, a physiological mechanism associated with brain plasticity.~During the intervention, the study team will conduct two pre-iTBS TMS measurements (Pre-20 and Pre-10). Participants will then complete iTBS-c (active comparator), which will be delivered unilaterally to the left motor cortex. Following iTBS-c, five post-iTBS TMS measurements (Post-0, 15, 30, 45, and 60) will be obtained. Motor evoked potentials (MEPs) will be recorded from the right abductor pollicis brevis (APB) muscle to assess the effects of the stimulation.~The MCF-B65 (active iTBS) and Cool-B65 A/P (sham/active iTBS) TMS coils will be used, alongside the MagPro R30 or the MagPro X100 TMS stimulators to deliver the intervention.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spaced iTBS
Description: Intermittent Theta-Burst Stimulation (iTBS) is a form of non-invasive brain stimulation that uses magnetic pulses applied to the scalp using a coil. iTBS will be used to stimulate the left motor cortex to enhance long-term potentiation (LTP)-like activity, a physiological mechanism associated with brain plasticity.~During the intervention, the study team will conduct two pre-iTBS TMS measurements (Pre-20 and Pre-10). Participants will then complete iTBS-s (experimental study intervention), which will be delivered unilaterally to the left motor cortex. Following iTBS-s, five post-iTBS TMS measurements (Post-0, 15, 30, 45, and 60) will be obtained. Motor evoked potentials (MEPs) will be recorded from the right abductor pollicis brevis (APB) muscle to assess the effects of the stimulation.~The MCF-B65 (active iTBS) and Cool-B65 A/P (sham/active iTBS) TMS coils will be used, alongside the MagPro R30 or the MagPro X100 TMS stimulators to deliver the intervention.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham iTBS
Description: Intermittent Theta-Burst Stimulation (iTBS) is a form of non-invasive brain stimulation that uses magnetic pulses applied to the scalp using a coil. iTBS will be used to stimulate the left motor cortex to enhance long-term potentiation (LTP)-like activity, a physiological mechanism associated with brain plasticity.~During the intervention, the study team will conduct two pre-iTBS TMS measurements (Pre-20 and Pre-10). Participants will then complete iTBS-sh (sham comparator), which will be delivered unilaterally to the left motor cortex. Following iTBS-sh, five post-iTBS TMS measurements (Post-0, 15, 30, 45, and 60) will be obtained. Motor evoked potentials (MEPs) will be recorded from the right abductor pollicis brevis (APB) muscle to assess the effects of the stimulation.~The MCF-P-B65 (sham iTBS), and Cool-B65 A/P (sham/active iTBS) TMS coils will be used, alongside the MagPro R30 or the MagPro X100 TMS stimulators to deliver the intervention.
Study: NCT04523350

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Instylla HES
Description: Instylla HES is a novel liquid embolic made of primarily water and polyethylene glycol (PEG)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TAE or cTACE
Description: Bland TAE or cTACE
Study: NCT05479890

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ClientBot
Description: ClientBot is an AI-based simulated client that supports skills improvement for providers learning and using Motivational Interviewing
Study: NCT06267989

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Extraction of the primary canine teeth
Description: Extraction of the primary teeth has show to be successful in some cases.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Expansion
Description: Expansion of the maxilla with rapid maxillary expander with no extractions
Study: NCT05059158

Intervention type: RADIATION
Intervention: positron emission tomography (PET)
Description: 18-Flutemetamol PET (clinical indicated) is going to be performed at the visit.

Intervention type: RADIATION
Intervention: positron emission tomography (PET)
Description: 18-Flutemetamol PET (clinical indicated) is going to be performed at the visit.

Intervention type: RADIATION
Intervention: positron emission tomography (PET)
Description: 18-Flutemetamol PET (clinical indicated) is going to be performed at the visit.
Study: NCT05856123

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SimPull Lateral Transfer Device
Description: Automated lateral transfer device
Study: NCT05008926

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naloxegol
Description: Administration of Naloxegol 25 mg per day by nasogastric tube (SNG) or orogastric tube (SOG). The administration should be started within the first 24 hours after the patient is admitted to intensive care and continued for the duration of the administration of the morphine derivative and until 48 hours after its discontinuation.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of the placebo according to the same procedures as the experimental arm.
Study: NCT05214417

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Injectable Solution
Description: 2 IM ketamine sessions with psychotherapy, spaced 9-15 days apart

Intervention type: OTHER
Group type: OTHER
Intervention: Naturalistic Control
Description: Continuation of pre-existing conventional treatment
Study: NCT05518903

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gallium Ga 68 FAPi-46
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study: NCT05327374

Intervention type: DIAGNOSTIC_TEST
Intervention: calculation of the inferior vena cava collapsibility index
Description: the ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(\>15%) of heart failure

Intervention type: DIAGNOSTIC_TEST
Intervention: calculation of the inferior vena cava collapsibility index
Description: the ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(\>15%) of heart failure
Study: NCT05199675

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Peer Support Training Program
Description: The digital peer support training program will consist of bite size modules on the four active ingredients of youth mental well-being, which will be delivered through training workshops, simulation activities, and homework assignments. The training will be conducted over 8 sessions, each lasting for 45-60 minutes following the typical duration of a school lesson on Character and Citizenship Education. The training workshops will be conducted as part of the school's Character and Citizenship Education lessons. The proficiency of participants in applying these digital support skills will be evaluated through simulation and homework activities, in which they apply the four active ingredients in their responses to mock letters that are adapted from actual cases of peer emotional disclosure. At the end of the training, adolescents are expected to apply the four active ingredients to the homework assignments on peers' emotional experiences.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Digital Peer Support Training Program
Description: The digital peer support training program will consist of bite size modules on the four active ingredients of youth mental well-being, which will be delivered through training workshops, simulation activities, and homework assignments. The training will be conducted over 8 sessions, each lasting for 45-60 minutes following the typical duration of a school lesson on Character and Citizenship Education. The training workshops will be conducted as part of the school's Character and Citizenship Education lessons. The proficiency of participants in applying these digital support skills will be evaluated through simulation and homework activities, in which they apply the four active ingredients in their responses to mock letters that are adapted from actual cases of peer emotional disclosure. At the end of the training, adolescents are expected to apply the four active ingredients to the homework assignments on peers' emotional experiences.
Study: NCT04654585

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The STOP intervention
Description: The stop intervention is a heath professional (medical doctor) led intervention assisting smokers with low socioeconomic position in their smoking cessation attempt. It consists of routine care and adapted advice supplemented with a free delivery of any or several type(s) of nicotine replacement therapy (NRT) (patches, inhalers, gum, tablets, etc.) and/or an e-cigarette + e-liquid. The delivery of those smoking aids is based on the smokers' preference and choice.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Participants randomised to the standard care group will be given standard care in assisting their smoking cessation attempt, but without free delivery of NRT or e-cigarettes.~Standard care includes motivational interviewing, advice to quit and prescription for NRTs. The number and online address of the French smoking cessation support helpline could also be provided. Health professionals will also be in position to prescribe NRT or other treatments (for example: Varenicline or Bupropion) which can help with smoking cessation, according to routine practice. The health professional could also give advice on e-cigarette use if he or she finds it suitable.
Study: NCT06318351

Intervention type: PROCEDURE
Intervention: transcutaneous acupoint electrical stimulation
Description: This is a safe and non-invasive procedure, similar to an electrode sheet, which applies a weak current to a specific site to achieve the purpose of acupoint stimulation.
Study: NCT06178965

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Incisional Hernia Repair by Abdominal Wall Component Release with Contemporary Onlay Mesh Fixation
Description: patients with incisional hernia will be operated by hernia reduction and sac closure followed by placement of onlay mesh after creating suitable flaps.
Study: NCT06104982

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NeuroTrac MyoPlus Pro single-channel electromyography biofeedback electrotherapy devices
Description: Neuromuscular electrical stimulation (NMES) is applied to intact second motor neurons and target muscles of patients with SCI and provides functional and therapeutic benefits in neurological rehabilitation. Functional electrical stimulation (FES) is a type of NMES that is used for electrical stimulation during exercises such as crunches. Newly used SiFES is a method in which the biofeedback-enabled FES device detects muscle contractions, and this electromyography (EMG) signal triggers the muscle stimulant mode of the device.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Isometric strengthening exercises
Description: Isometric abdominal strengthening exercises are part of the standard rehabilitation program for individuals with spinal cord injuries.
Study: NCT05838404

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M-O-M-S on the Bayou
Description: Peer and mentor support and meetings across pregnancy
Study: NCT05837520

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: i-BiSSkApp (tablet application) with swallowing therapy
Description: The device, International Biofeedback Strength and Skill App (i-BiSSkApp) is an at-home swallowing biofeedback tool (hardware and software) to target rehabilitation of both skill and strength of swallowing function. The program utilizes submental surface electromyography coupled with a user-friendly interface to display visual feedback of swallowing strength and timing.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional behavioral swallowing therapy
Description: Participants will receive standard behavioral swallowing exercises based on the results of a swallowing evaluation. Participants will complete daily at-home exercises with written and verbal instructions and return weekly to clinic for 12 weeks of therapy.
Study: NCT05940922

Intervention type: OTHER
Intervention: No intervention. Retrospective observation only.
Description: No intervention. Retrospective observation only.
Study: NCT05990751

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GD2 CAR T cells
Description: The GD2 CAR T cells target GD2 positive cells. The cells also express transgenes that aim to increase their resistance within the tumour microenvironment.
Study: NCT05166915

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: UVA Light Emitting Catheter
Description: Experimental Device intended to eliminate microorganisms using UV-A light, thereby reducing the viral burden of SARS-CoV-2

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Control Catheter
Description: Sham Control Device
Study: NCT04778345

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPI PET/CT scan
Description: Each subject receives a single intravenous injection of 68Ga-FAPI, and undergo PET/CT imaging after 18F-FDG PET/CT scan during 2 days and 1 week.
Study: NCT05761054

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: RT
Description: The treatment will be administered in 25 daily fractions (Monday-Friday) at the disease site to include the region of suspected micrometastatic spread (Clinical Target Volume 1, CTV1) at a dose of 50 Gy (2Gy~/ fraction) with SIB intensification on volume reduced corresponding to the interface sites between the tumor and the vascular / nerve axes (Clinical Target Volume 2, CTV2) at a dose of 60 Gy (2.4 Gy / fraction). The association with neoadjuvant chemotherapy based on anthracyclines is allowed.
Study: NCT05525728

Intervention type: OTHER
Group type: OTHER
Intervention: Neurosensory
Description: Physiological and neurophysiological investigations
Study: NCT06161662

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: transcutaneous electrical acupoint stimulation
Description: Electrodes will be attached on the surface of acupoints and electrical stimulation will be given

Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Electrodes will be attached on the surface of acupoints but no stimulation will be given